Search results for "610"

showing 10 items of 1353 documents

A New Off-Pump Hybrid Open and Endovascular Repair to Treat Ductus Botalli and Ascendens Aneurysms

2012

To report a combined ascending aorta and aortic arch hybrid repair, we performed off-pump with no aortic graft replacement. A 65-year-old man, developing progressive recurrent laryngeal nerve paralysis, underwent a computed tomography (CT) angiography detecting nonpatent residual ductus Botalli aneurysm and ascending aorta aneurysm. Due to severe multimorbidities, a less-invasive alternative was elaborated. In a first step, appropriate proximal landing zone for aortic stent grafting was achieved by ascending aorta diameter reduction, with epiaortic wrapping, and debranching the supra-aortic trunks. In the second step, endovascular stent grafts were deployed from proximal ascending aorta to…

MaleAortic archmedicine.medical_specialtyAortographymedicine.medical_treatment610 Medicine & healthAorta ThoracicAortographySettore MED/22 - Chirurgia Vascolare2705 Cardiology and Cardiovascular MedicineBlood Vessel Prosthesis ImplantationAortic aneurysmAneurysmmedicine.arteryAscending aortamedicineHumansThoracic aortacardiovascular diseasesDuctus Arteriosus PatentAgedCardiopulmonary Bypassmedicine.diagnostic_test10042 Clinic for Diagnostic and Interventional Radiologybusiness.industryEndovascular Proceduresaortic arch aortic operation carotid afteries endovascular procedures vascular diseaseStentGeneral Medicinemedicine.disease10020 Clinic for Cardiac Surgery2746 SurgeryAortic AneurysmSurgeryTreatment Outcomesurgical procedures operativeDescending aortacardiovascular systemSurgeryRadiologyTomography X-Ray ComputedCardiology and Cardiovascular MedicinebusinessVascular and Endovascular Surgery
researchProduct

Chimney and periscope grafts observed over 2 years after their use to revascularize 169 renovisceral branches in 77 patients with complex aortic aneu…

2013

^ ^Purpose: To evaluate the performance of periscope and/or chimney grafts (CPGs) in theendovascular treatment of pararenal or thoracoabdominal aneurysms using off-the-shelfdevices.Methods: Between February 2002 and August 2012, 77 consecutive patients (62 men; meanage 7369 years) suffering from pararenal aortic (n¼55), thoracoabdominal (n¼16), or arch tovisceral artery aneurysms (n¼6) were treated with aortic stent-graft implantation requiringchimney and/or periscope grafts to maintain side branch perfusion. CPGs were planned inadvance and were not used as bailout. A standardized follow-up protocol includingcomputed tomographic angiography, laboratory testing, and clinical examination wasp…

MaleAortic archmedicine.medical_specialtyTime FactorsEndoleakmedicine.medical_treatment610 Medicine & healthKaplan-Meier EstimateProsthesis DesignAortographyEndovascular aneurysm repair2705 Cardiology and Cardiovascular MedicineBlood Vessel Prosthesis ImplantationAortic aneurysmAneurysmBlood vessel prosthesismedicine.arterymedicineHumans2741 Radiology Nuclear Medicine and ImagingRadiology Nuclear Medicine and imagingRenal arteryVascular PatencyAgedRetrospective StudiesAged 80 and overAortic Aneurysm Thoracicmedicine.diagnostic_testbusiness.industry10042 Clinic for Diagnostic and Interventional RadiologyEndovascular ProceduresMiddle Agedmedicine.diseaseBlood Vessel ProsthesisSurgery10020 Clinic for Cardiac Surgery2746 SurgeryTreatment Outcomemedicine.anatomical_structureAngiographyFemaleStentsSurgeryRadiologyTomography X-Ray ComputedCardiology and Cardiovascular MedicinebusinessAortic Aneurysm AbdominalArtery
researchProduct

THE DISTRIBUTION OF UDP-GLUCURONOSYLTRANSFERASES IN RAT-LIVER PARENCHYMAL AND NONPARENCHYMAL CELLS

1992

Activities for the glucuronidation of 1-naphthol, morphine and bilirubin as well as for the sulfation of 2-naphthol have been determined in homogenates of parenchymal, Kupffer and endothelial cells isolated from livers of untreated and Aroclor 1254-pretreated rats. In addition, Western blot analyses using different polyclonal antibodies against UDP-glucuronosyltransferases (UDP-GTs) were performed with similar preparations. All enzymes under investigation were expressed at high levels in liver parenchymal cells. The constitutive expression and inducibility of UDP-GT isozyme(s) for 1-naphthol glucuronidation was also clearly demonstrated in Kupffer and endothelial cells. Furthermore, the pre…

MaleAroclorsCell type1303 BiochemistryKupffer CellsLiver cytologyBilirubinBlotting WesternGlucuronidation10050 Institute of Pharmacology and Toxicology610 Medicine & healthCell SeparationBiologyBiochemistryIsozymechemistry.chemical_compoundSulfationmedicineAnimalsEndotheliumGlucuronosyltransferasePharmacologyKupffer cellRats Inbred StrainsChlorodiphenyl (54% Chlorine)ArylsulfotransferaseMolecular biologyRatsIsoenzymesEndothelial stem cellmedicine.anatomical_structure3004 PharmacologyLiverchemistryBiochemistry570 Life sciences; biology
researchProduct

Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics

2022

AbstractIn prostate cancer (PCa), the use of new radiopharmaceuticals has improved the accuracy of diagnosis and staging, refined surveillance strategies, and introduced specific and personalized radioreceptor therapies. Nuclear medicine, therefore, holds great promise for improving the quality of life of PCa patients, through managing and processing a vast amount of molecular imaging data and beyond, using a multi-omics approach and improving patients’ risk-stratification for tailored medicine. Artificial intelligence (AI) and radiomics may allow clinicians to improve the overall efficiency and accuracy of using these “big data” in both the diagnostic and theragnostic field: from technical…

MaleArtificial intelligencePositron emission tomographyProstate cancerRadiomicsTheragnosticsProstatic Neoplasms610 Medicine & health10181 Clinic for Nuclear MedicineMultimodal ImagingImage Processing Computer-AssistedQuality of Life2741 Radiology Nuclear Medicine and ImagingHumansRadiology Nuclear Medicine and imaging
researchProduct

Honeybees produce millimolar concentrations of non-neuronal acetylcholine for breeding: possible adverse effects of neonicotinoids

2016

The worldwide use of neonicotinoid pesticides has caused concern on account of their involvement in the decline of bee populations, which are key pollinators in most ecosystems. Here we describe a role of non-neuronal acetylcholine (ACh) for breeding of Apis mellifera carnica and a so far unknown effect of neonicotinoids on non-target insects. Royal jelly or larval food are produced by the hypopharyngeal gland of nursing bees and contain unusually high ACh concentrations (4–8 mM). ACh is extremely well conserved in royal jelly or brood food because of the acidic pH of 4.0. This condition protects ACh from degradation thus ensuring delivery of intact ACh to larvae. Raising the pH to ≥5.5 and…

MaleB Vitamins0301 basic medicineInsecticideslcsh:MedicineToxicologychemistry.chemical_compoundLarvae0302 clinical medicineRoyal jellyMedicine and Health SciencesPollinationlcsh:ScienceNeuronsLiquid ChromatographyLarvaMultidisciplinarybiologyOrganic CompoundsReproductionChromatographic TechniquesVitaminsBeesNitro CompoundsThiaclopridInsectsChemistryLarvaPhysical SciencesFemaleHoney BeesMuscle ContractionResearch Articlefood.ingredientArthropodaGuinea PigsCholinesResearch and Analysis MethodsAnabasineCholine O-Acetyltransferase03 medical and health sciencesfoodAdverse Reactionsddc:570Animalsddc:610Immunohistochemistry TechniquesNutritionCholinesterasePharmacologyMetamorphosisOrganic Chemistrylcsh:RfungiOrganismsChemical CompoundsNeonicotinoidBiology and Life SciencesClothianidinMuscle SmoothPesticideInvertebratesHymenopteraAcetylcholineHigh Performance Liquid ChromatographyBroodDietHistochemistry and Cytochemistry TechniquesHypopharynx030104 developmental biologychemistryImmunologic Techniquesbiology.proteinlcsh:Q030217 neurology & neurosurgeryDevelopmental Biology
researchProduct

Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial

2019

Gislason, Gunnar H/0000-0002-0548-402X; Malynovsky, Yaroslav V/0000-0002-9118-1104; Bhatt, Deepak L./0000-0002-1278-6245; Nikolaev, Konstantin/0000-0003-4601-6203; Sherwood, Matthew/0000-0002-4305-5883; Chumakova, Galina A/0000-0002-2810-6531; Raffel, Owen C/0000-0001-5470-7050; Leonardi, Sergio/0000-0002-4800-6132; Tse, Hung Fat/0000-0002-9578-7808; Reshetko, Olga/0000-0003-3107-7636; Pereira, Helder/0000-0001-8656-4883; Racca, Vittorio/0000-0002-4465-3789; Podoleanu, Cristian/0000-0001-9987-2519; Ersanli, Murat/0000-0003-1847-3087; Muenzel, Thomas/0000-0001-5503-4150; Sandhu, Manjinder/0000-0003-2538-2079; Taskinen, Marja-Riitta/0000-0002-6229-3588; bastos, jose/0000-0002-9526-3123; Manak…

MaleBIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences.Cardiac & Cardiovascular SystemsMyocardial InfarctionUNIVERSAL DEFINITION030204 cardiovascular system & hematologyTHERAPYDISEASEchemistry.chemical_compound0302 clinical medicineCardiac and Cardiovascular Systems030212 general & internal medicineMyocardial infarctionProspective Studies1102 Cardiorespiratory Medicine and HaematologyOxygen supplyKardiologiBIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti.CHOLESTEROLMiddle AgedMI typesCardiologyLDL Cholesterol LipoproteinsFemaleCardiology and Cardiovascular MedicineLife Sciences & Biomedicinemedicine.medical_specialty610ODYSSEY OUTCOMES InvestigatorsAntibodies Monoclonal HumanizedCLASSIFICATION03 medical and health sciencesDouble-Blind MethodInternal medicinemedicineHumansddc:610Alirocumab ; MI types ; Mortality ; PreventionMortalityMETAANALYSISAlirocumabAgedScience & TechnologyTask forceCholesterolbusiness.industryEVOLOCUMABPrevention1103 Clinical SciencesCholesterol LDLmedicine.diseaseEvolocumabchemistryCardiovascular System & HematologyCardiovascular System & CardiologyHuman medicinebusinessAlirocumab
researchProduct

Predictability of oppositional defiant disorder and symptom dimensions in children and adolescents with ADHD combined type.

2010

BackgroundOppositional defiant disorder (ODD) is frequently co-occurring with attention deficit hyperactivity disorder (ADHD) in children and adolescents. Because ODD is a precursor of later conduct disorder (CD) and affective disorders, early diagnostic identification is warranted. Furthermore, the predictability of three recently confirmed ODD dimensions (ODD-irritable, ODD-headstrong and ODD-hurtful) may assist clinical decision making.MethodReceiver-operating characteristic (ROC) analysis was used in order to test the diagnostic accuracy of the Conners' Parent Rating Scale revised (CPRS-R) and the parent version of the Strength and Difficulties Questionnaire (PSDQ) in the prediction of …

MaleBOYSPsychometricsSocial Sciences3202 Applied PsychologyDevelopmental psychology2738 Psychiatry and Mental Health0302 clinical medicineDEFICIT-HYPERACTIVITY DISORDEROPERATING CHARACTERISTIC ANALYSISPerception and Action [DCN 1]ChildDIFFICULTIES QUESTIONNAIRE SDQApplied PsychologyMental Health [NCEBP 9]Parenting05 social sciencesANTISOCIAL-BEHAVIORLONGITUDINAL COURSE10058 Department of Child and Adolescent PsychiatryPrognosisConfirmatory factor analysisPsychiatry and Mental healthConduct disorderAttention Deficit and Disruptive Behavior DisordersChild PreschoolRegression AnalysisFemalemedicine.symptomPsychology050104 developmental & child psychologyAdolescenteducation610 Medicine & healthIrritabilityEXECUTIVE DYSFUNCTION03 medical and health sciencesRating scalePredictive Value of Testsmental disordersmedicineAttention deficit hyperactivity disorderHumans0501 psychology and cognitive sciencesBEHAVIOR CHECKLISTPsychiatric Status Rating ScalesParent Rating Scalesmedicine.disease030227 psychiatryROC CurveRATING-SCALESAttention Deficit Disorder with HyperactivityCONDUCT DISORDERExecutive dysfunction
researchProduct

The Anticonvulsant FCE 26743 is a Selective and Short-acting MAO-B Inhibitor Devoid of Inducing Properties towards Cytochrome P450-dependent Testoste…

1994

Abstract The effects of the potent anticonvulsant FCE 26743 ((S)-2-(4-(3-fluorobenzyloxy)benzylamino)propionamide) on monoamine oxidase (MAO) activity were measured in-vitro and ex-vivo using rat tissue homogenates. In-vitro, FCE 26743 showed potent and selective inhibitory properties towards liver MAO-B, with IC50 values about 10−7  m for MAO-B and higher than 10−5  m for MAO-A. When determined ex-vivo in brain, the ED50 value for the inhibition of MAO-B was 1·1 mg kg−1 (p.o.) 1 h post-dosing, whereas MAO-A remained virtually unaffected after administration of 60 mg kg−1. Similar effects were seen in liver. Following oral administration of 5 mg kg−1 FCE 26743 to rats, brain MAO-B inhibitio…

MaleBenzylaminesMonoamine Oxidase InhibitorsMonoamine oxidaseMetabolite3003 Pharmaceutical Science10050 Institute of Pharmacology and ToxicologyPharmaceutical Science610 Medicine & healthMice Inbred StrainsIn Vitro TechniquesPharmacologyHydroxylationRats Sprague-DawleyHydroxylationMicechemistry.chemical_compoundCytochrome P-450 Enzyme SystemOral administrationmedicineAnimalsTestosteroneED50PharmacologyAlanineDose-Response Relationship DrugbiologyChemistryBrainCytochrome P450Rats3004 PharmacologyLiverMechanism of actionbiology.protein570 Life sciences; biologyAnticonvulsantsMonoamine oxidase Bmedicine.symptomJournal of Pharmacy and Pharmacology
researchProduct

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 tria…

2019

© 2019 Elsevier Ltd. All rights reserved.

MaleBiopsyClinical Trial Phase IIIAdministration Oral030204 cardiovascular system & hematologyChronic liver diseaseSettore MED/04Biomarkers/analysisGastroenterologychemistry.chemical_compound0302 clinical medicine/dk/atira/pure/researchoutput/pubmedpublicationtype/D013485Liver Function TestsNon-alcoholic Fatty Liver DiseaseClinical endpointMedicine030212 general & internal medicine610 Medicine & healthChenodeoxycholic Acid/administration & dosageeducation.field_of_studyLiver Function TestResearch Support Non-U.S. Gov'tFatty liverObeticholic acidNASH OBETICHOLIC ACIDGeneral Medicine/dk/atira/pure/researchoutput/pubmedpublicationtype/D052061Middle AgedMulticenter Study/dk/atira/pure/researchoutput/pubmedpublicationtype/D016448Randomized Controlled TrialAdministrationFemale/dk/atira/pure/researchoutput/pubmedpublicationtype/D016449Administration Oral; Biomarkers; Biopsy; Chenodeoxycholic Acid; Double-Blind Method; Female; Humans; Liver Function Tests; Male; Middle Aged; Non-alcoholic Fatty Liver DiseaseHumanOralmedicine.medical_specialtyPopulationPlaceboChenodeoxycholic Acid03 medical and health sciencesResearch Support N.I.H. ExtramuralDouble-Blind MethodInternal medicineJournal ArticleHumans/dk/atira/pure/researchoutput/pubmedpublicationtype/D017428educationIntention-to-treat analysisbusiness.industryBiomarkerInterim analysismedicine.diseaseNon-alcoholic Fatty Liver Disease/drug therapychemistryHuman medicine/dk/atira/pure/researchoutput/pubmedpublicationtype/D016428businessBiomarkersAdministration; Oral; Biomarkers; Biopsy; Chenodeoxycholic Acid; Double-Blind Method; Female; Humans; Liver Function Tests; Male; Middle Aged; Non-alcoholic Fatty Liver Disease
researchProduct

Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial

2012

Aims High-density lipoprotein cholesterol (HDL-C) is inversely associated with cardiovascular (CV) events and thus an attractive therapeutic target. However, in spite of marked elevations in HDL-C, the first cholesterol transport protein (CETP) inhibitor torcetrapib raised blood pressure (BP), impaired endothelial function, and increased CV mortality and morbidity. Dalcetrapib is a novel molecule acting on CETP with a different chemical structure to torcetrapib. As HDL stimulates nitric oxide (NO), suppresses inflammation, and exerts protective CV effects, we investigated the effects of dalcetrapib on endothelial function, blood pressure, inflammatory markers, and lipids in patients with, o…

MaleBrachial ArteryBlood PressureCoronary Diseasechemistry.chemical_compoundAnacetrapibTorcetrapibMedicineLipoproteinbiologyAnticholesteremic AgentsEstersMiddle AgedVasodilationTreatment OutcomeCardiologyFemalelipids (amino acids peptides and proteins)Cardiology and Cardiovascular MedicineBlood Flow Velocitymedicine.medical_specialtyAmbulatory blood pressureDalcetrapibHypercholesterolemia610 Medicine & healthPlacebo142-005 142-0052705 Cardiology and Cardiovascular MedicineCholesterol (HDL-C)Double-Blind MethodInternal medicineCholesterylester transfer proteinDalcetrapibHumansSulfhydryl CompoundsTriglyceridesAgedbusiness.industryCholesterol HDLTorcetrapibCholesterol LDLAmidesFasttrack ClinicalCholesterol Ester Transfer ProteinsEndocrinologyBlood pressurechemistrybiology.proteinHigh-density570 Life sciences; biologyEndothelium VascularbusinessBiomarkersEvacetrapibEuropean heart journal
researchProduct